Bordado, Letecia D.
HRN: 29-46-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/07/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/07/2026
08/14/2026
IM
600mg
Q 6
DM Foot
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: